During the past decade, Mercy Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 25 clinical trials were completed, i.e. on average, 2500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital" #1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital" are "Breast Cancer" (4 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials), "Fallopian Tube Mucinous Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials) and "Ovarian Endometrioid Adenocarcinoma" (3 trials). Many other conditions were trialed in "Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Hospital" are "Drug" (31 trials), "Other" (22 trials), "Biological" (18 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Bevacizumab" (13 trials), "Quality-of-Life Assessment" (10 trials), "Paclitaxel" (8 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital" are 20 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Hospital". undefined are not yet recruiting, undefined are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Mercy Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".